Genome–wide association studies provide new insights into type 2 diabetes aetiology

Human geneticists are currently in the middle of a race. Thanks to a new technology in the form of 'genome-wide chips', investigators can potentially find many novel disease genes in one large experiment. Type 2 diabetes has been hot out of the blocks with six recent publications that together provide convincing evidence for six new gene regions involved in the condition. Together with candidate approaches, these studies have identified 11 confirmed genomic regions that alter the risk of type 2 diabetes in the European population. One of these regions, the fat mass and obesity associated gene (FTO), represents by far the best example of an association between common variation and fat mass in the general population.

[1]  J. Neel.  The genetics of diabetes mellitus. , 1970, Advances in metabolic disorders.

[2]  J. Neel.  Diabetes Mellitus — A Geneticist’s Nightmare , 1976 .

[3]  M. Mattéi,et al.  Programmed cell death is affected in the novel mouse mutant Fused toes (Ft). , 1994, Development.

[4]  J. Takeda,et al.  Frameshift Mutation, A263fsinsGG, in the Hepatocyte Nuclear Factor-1β Gene Associated With Diabetes and Renal Dysfunction , 1998, Diabetes.

[5]  P. Behn,et al.  A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome) , 1998, Nature Genetics.

[6]  S. O’Rahilly,et al.  Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension , 1999, Nature.

[7]  Eric S. Lander,et al.  The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes , 2000, Nature Genetics.

[8]  Tom H. Lindner,et al.  Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus , 2000, Nature Genetics.

[9]  T. Hansen,et al.  The E 23 K Variant of Kir 6 . 2 Associates With Impaired Post – OGTT Serum Insulin Response and Increased Risk of Type 2 Diabetes , 2003 .

[10]  T. Hansen,et al.  The E23K variant of Kir6.2 associates with impaired post-OGTT serum insulin response and increased risk of type 2 diabetes. , 2003, Diabetes.

[11]  M. McCarthy,et al.  Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes. , 2003, Diabetes.

[12]  M. Daly,et al.  Haplotype structure and genotype-phenotype correlations of the sulfonylurea receptor and the islet ATP-sensitive potassium channel gene region. , 2004, Diabetes.

[13]  R. Beddington,et al.  Hex homeobox gene-dependent tissue positioning is required for organogenesis of the ventral pancreas , 2004, Development.

[14]  S. O’Rahilly,et al.  Type 2 (non-insulin-dependent) diabetes mellitus new genetics for old nightmares , 1988, Diabetologia.

[15]  F. Ashcroft,et al.  Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. , 2004, The New England journal of medicine.

[16]  K. Mikoshiba,et al.  Cdk5-dependent regulation of glucose-stimulated insulin secretion , 2005, Nature Medicine.

[17]  H. Stefánsson,et al.  Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes , 2006, Nature Genetics.

[18]  J. Habener,et al.  Inhibition of Cyclin-dependent Kinase 5 Activity Protects Pancreatic Beta Cells from Glucotoxicity* , 2006, Journal of Biological Chemistry.

[19]  K. Ligon,et al.  p16INK4a induces an age-dependent decline in islet regenerative potential , 2006, Nature.

[20]  J. Gulcher,et al.  A variant in CDKAL1 influences insulin response and risk of type 2 diabetes , 2007, Nature Genetics.

[21]  M. McCarthy,et al.  Common variants in WFS1 confer risk of type 2 diabetes , 2007, Nature Genetics.

[22]  T. Hudson,et al.  A genome-wide association study identifies novel risk loci for type 2 diabetes , 2007, Nature.

[23]  M. McCarthy,et al.  Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes , 2007, Science.

[24]  D. Gudbjartsson,et al.  Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes , 2007, Nature Genetics.

[25]  Jonathan C. Cohen,et al.  A Common Allele on Chromosome 9 Associated with Coronary Heart Disease , 2007, Science.

[26]  M. Jarvelin,et al.  A Common Variant in the FTO Gene Is Associated with Body Mass Index and Predisposes to Childhood and Adult Obesity , 2007, Science.

[27]  M. McCarthy,et al.  Variation in TCF7L2 Influences Therapeutic Response to Sulfonylureas , 2007, Diabetes.

[28]  Beverley Balkau,et al.  Variation in FTO contributes to childhood obesity and severe adult obesity , 2007, Nature Genetics.

[29]  Lester L. Peters,et al.  Genome-wide association study identifies novel breast cancer susceptibility loci , 2007, Nature.

[30]  Kristin G Ardlie,et al.  Evaluation of Common Variants in the Six Known Maturity-Onset Diabetes of the Young (MODY) Genes for Association With Type 2 Diabetes , 2007, Diabetes.

[31]  Marcia M. Nizzari,et al.  Genome-Wide Association Analysis Identifies Loci for Type 2 Diabetes and Triglyceride Levels , 2007, Science.

[32]  Simon C. Potter,et al.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.

[33]  P. Donnelly,et al.  Replicating genotype–phenotype associations , 2007, Nature.

[34]  A. Gylfason,et al.  A Common Variant on Chromosome 9p21 Affects the Risk of Myocardial Infarction , 2007, Science.

[35]  G. Abecasis,et al.  A Genome-Wide Association Study of Type 2 Diabetes in Finns Detects Multiple Susceptibility Variants , 2007, Science.